Zurich Cantonal Bank
GEVA

Zurich Cantonal Bank’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Zurich Cantonal Bank’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-599
Closed -$58K – 2169
2015
Q1 		$58K Buy
+599
New +$63.4K ﹤0.01% 993

Zurich Cantonal Bank's GEVA Position: Q2 2015 in Review

Zurich Cantonal Bank sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 599 shares — an estimated $58K sold.

Zurich Cantonal Bank first reported a position in GEVA in Q1 2015 and held it in 1 quarter. The position peaked at $58K in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Zurich Cantonal Bank reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Zurich Cantonal Bank sold 599 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $58K.
  • Zurich Cantonal Bank first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • Zurich Cantonal Bank's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $58K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Zurich Cantonal Bank's 13F filing for Q2 2015, filed 11 Aug 2015.